Semnur Pharmaceuticals, Inc.
SMNR
$9.00
$0.000.00%
OTC PK
| 09/30/2025 | 06/30/2025 | 03/31/2025 | 09/30/2024 | ||
|---|---|---|---|---|---|
| Total Cash And Short-Term Investments | 85.00K | 55.00K | 7.00K | -- | |
| Total Receivables | -- | -- | -- | -- | |
| Inventory | -- | -- | -- | -- | |
| Prepaid Expenses | -- | -- | -- | -- | |
| Finance Division Loans and Leases Current | -- | -- | -- | -- | |
| Total Finance Division Other Current Assets | -- | -- | -- | -- | |
| Other Current Assets | -- | 8.34M | 6.82M | -- | |
| Total Current Assets | 85.00K | 8.39M | 6.82M | -- | |
|
|
|||||
| Total Current Assets | 85.00K | 8.39M | 6.82M | -- | |
| Net Property, Plant & Equipment | 689.00K | 689.00K | 689.00K | -- | |
| Long-term Investments | -- | -- | -- | -- | |
| Goodwill | -- | -- | -- | -- | |
| Total Other Intangibles | -- | -- | -- | -- | |
| Finance Div Loans & Leases LT | -- | -- | -- | -- | |
| Total Finance Div Other LT Assets | -- | -- | -- | -- | |
| Total Other Assets | -- | -- | -- | -- | |
| Total Assets | 774.00K | 9.08M | 7.51M | -- | |
|
|
|||||
| Total Accounts Payable | 4.29M | -- | -- | -- | |
| Total Accrued Expenses | 1.27M | 1.33M | 184.00K | -- | |
| Short-term Debt | 4.48M | -- | -- | -- | |
| Current Portion of Long-Term Debt/Capital Leases | -- | -- | -- | -- | |
| Finance Division Debt Current | -- | -- | -- | -- | |
| Total Finance Division Other Current Liabilities | -- | 23.00K | 23.00K | -- | |
| Total Other Current Liabilities | -- | 23.00K | 23.00K | -- | |
| Total Current Liabilities | 10.03M | 1.36M | 207.00K | -- | |
|
|
|||||
| Total Current Liabilities | 10.03M | 1.36M | 207.00K | -- | |
| Long-Term Debt | 5.34M | 52.17M | 50.76M | -- | |
| Short-term Debt | 4.48M | -- | -- | -- | |
| Capital Leases | -- | -- | -- | -- | |
| Finance Division Debt Non Current | -- | -- | -- | -- | |
| Total Finance Division Other Non Current Liabilities | -- | -- | -- | -- | |
| Total Other Liabilities | -- | -- | -- | -- | |
| Total Liabilities | 15.37M | 53.53M | 50.96M | -- | |
|
|
|||||
| Common Stock & APIC | 255.05M | 72.60M | 72.60M | -- | |
| Retained Earnings | -269.64M | -117.05M | -116.05M | -- | |
| Treasury Stock & Other | -- | -- | -- | -- | |
| Total Common Equity | -14.59M | -44.45M | -43.45M | -- | |
|
|
|||||
| Preferred Stock Redeemable | -- | -- | -- | -- | |
| Preferred Stock Non Redeemable | -- | -- | -- | -- | |
| Preferred Stock Convertible | 1.00K | -- | -- | -- | |
| Preferred Stock, Others | -- | -- | -- | -- | |
| Total Preferred Equity | 1.00K | -- | -- | -- | |
|
|
|||||
| Total Common Equity | -14.59M | -44.45M | -43.45M | -- | |
| Total Preferred Equity | 1.00K | -- | -- | -- | |
| Total Minority Interest | -- | -- | -- | -- | |
| Total Equity | -14.59M | -44.45M | -43.45M | -- | |
|
|
|||||